Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Newly patented hydrazine derivatives from Roche inhibit TNF-alpha release

Feb. 4, 2000

Amarillo Biosciences' oral interferon alfa granted orphan drug status for Behcet's disease

Feb. 4, 2000

Hydroxamic acid-based MMP inhibitors in the DuPont pipeline

Feb. 1, 2000

Antisense oligonucleotides targeting TNFR1 expression designed at Isis

Feb. 1, 2000

RCT patents GH treatment regimen for rheumatoid arthritis

Jan. 31, 2000

Gene-based osteoarthritis collaboration initiated by Quark and Shionogi

Jan. 28, 2000

FDA approves new labeling for Hyalgan

Jan. 28, 2000

FDA allows NicOx to begin phase I trials of NO-NSAID

Jan. 27, 2000

Novel MCP-1 antagonists emerge from Warner-Lambert research

Jan. 27, 2000

Scios discusses plans for p38 kinase inhibitors

Jan. 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...